STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLMT
  4. [Form 4] Calumet, Inc. /DE Insider Trading Activity

[Form 4] Calumet, Inc. /DE Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Amy M. Schumacher, a director of Calumet, Inc. (CLMT), reported receipt of 3,796 restricted stock units on 06/24/2025. The RSUs are described as the economic equivalent of one share each and are 100% vested. Each RSU is payable either in one share of Calumet common stock or the cash value thereof, and the reported acquisition price is $0 (reflecting issuance/settlement of RSUs rather than a cash purchase). The report lists 246,040 shares as the amount of securities beneficially owned following the transaction. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 10/03/2025.

Amy M. Schumacher, una direttrice di Calumet, Inc. (CLMT), ha riportato la ricezione di 3.796 unità azionarie ristrette (RSU) il 24/06/2025. Le RSU sono descritte come l'equivalente economico di una singola quota e sono al 100% vestite. Ogni RSU è pagabile sia in una quota di azioni ordinarie Calumet sia nel contante equivalente, e il prezzo di acquisizione dichiarato è $0 (riflettendo l’emissione/settlement delle RSU piuttosto che un acquisto in contanti). Il rapporto riporta 246.040 azioni come importo di titoli di proprietà dopo la transazione. Il Form 4 è stato firmato da un procuratore-in-fatto per conto della persona che riporta il dato il 03/10/2025.

Amy M. Schumacher, directora de Calumet, Inc. (CLMT), informó haber recibido 3,796 unidades de stock restringido (RSU) el 24/06/2025. Se describe que las RSU son el equivalente económico de una acción cada una y están 100% vestidas. Cada RSU es pagadera ya sea en una acción ordinaria de Calumet o en su equivalente en efectivo, y el precio de adquisición informado es $0 (reflejando laemisión/ liquidación de RSU en lugar de una compra en efectivo). El informe lista 246,040 acciones como la cantidad de valores poseídos de manera beneficiosa tras la transacción. El Formulario 4 fue firmado por un apoderado en nombre de la persona informante el 03/10/2025.

Amy M. Schumacher, Calumet, Inc. (CLMT)의 이사로서, 2025년 6월 24일에 3,796개의 제한 주식 단위(RSU) 수령을 보고했습니다. RSU는 주당 경제적 등가물로 설명되며 전액 취득 상태입니다. 각 RSU는 Calumet 일반 주식 한 주 또는 그 현금가로 지급될 수 있으며 보고된 취득가액은 $0로 RSU의 발행/정산을 반영하는 현금 구매가 아님을 나타냅니다. 보고서는 거래 후 실제로 보유한 증권의 수량으로 246,040주를 기재합니다. Form 4는 보고자를 대신하여 대리인(법정대리인)이 2025년 10월 3일에 서명했습니다.

Amy M. Schumacher, directrice de Calumet, Inc. (CLMT), a signalé avoir reçu 3 796 unités d’actions restreintes (RSU) le 24/06/2025. Les RSU sont décrites comme l’équivalent économique d’une action et sont entierement acquises. Chaque RSU peut être payable soit en une action ordinaire Calumet, soit pour leur valeur en espèces, et le prix d’acquisition rapporté est $0 (reflétant l’émission/ liquidéation des RSU plutôt qu’un achat en numéraire). Le rapport indique 246 040 actions comme le montant des titres d’actifs détenus avantageusement après la transaction. Le Formulaire 4 a été signé par un mandataire au nom de la personne qui signale le document le 03/10/2025.

Amy M. Schumacher, Direktorin von Calumet, Inc. (CLMT), hat den Erhalt von 3.796 eingeschränkten Aktieneinheiten (RSU) am 24.06.2025 gemeldet. Die RSUs werden als wirtschaftliches Äquivalent zu einer Aktie beschrieben und sind vollständig vestet. Jede RSU ist entweder in einer Calumet-Ordinary-Share oder deren Barwert zahlbar, und der gemeldete Anschaffungspreis beträgt $0 (spiegelt die Ausgabe/Abwicklung der RSU wider statt eines Barankaufs). Der Bericht listet 246.040 Aktien als den Betrag der vorteilhaft gehaltenen Wertpapiere nach der Transaktion. Das Formular 4 wurde am 03.10.2025 von einem Bevollmächtigten im Namen der meldenden Person unterschrieben.

Amy M. Schumacher، عضو مدير في Calumet, Inc. (CLMT)، أفادت بتلقي 3,796 وحدات أسهم مقيدة (RSU) في 24/06/2025. وتوصف RSUs بأنها مكافئ اقتصادي لسهم واحد وتكون مكتملة الاستحقاق بنسبة 100%. كل RSU قابلة للدفع إما في سهم عادي واحد من Calumet أو بقيمته النقدية، ويُذكر سعر الاكتساب المدون بــ $0 (يعكس إصدار/تسوية RSU بدلاً من شراء نقدي). يذكر التقرير 246,040 سهماً كإجمالي الأوراق المالية المملوكة فائدةً بعد الصفقة. تم توقيع نموذج 4 من قبل وكيل قانوني نيابة عن الشخص المبلغ في 03/10/2025.

Amy M. Schumacher，是Calumet, Inc. (CLMT)的董事之一，报告于2025-06-24收到3,796份受限股票单位（RSU）。RSU被描述为每股的经济等值，且为100% 已归属。每份RSU可以Calumet普通股的一股或其等值现金支付，且披露的取得价格为$0（反映RSU的发行/结算，而非现金购买）。报告将交易后实际拥有的证券数量列为246,040股。Form 4由一名代理律师代表申报人于2025-10-03签署。

Positive
  • 3,796 Restricted Stock Units were acquired, and they are 100% vested
  • RSUs are payable in one share each or cash, providing flexibility at settlement
  • Reporting person identified as Amy M. Schumacher, a director, improving disclosure clarity
Negative
  • None.

Insights

Director received 3,796 vested RSUs on 06/24/2025.

The filing shows 3,796 Restricted Stock Units were acquired and are 100% vested, meaning the reporting person has an immediate economic interest in those units. The RSUs convert into one share each or cash at settlement, and the transaction price is reported as $0, which is typical for compensation-related awards that vest rather than open-market purchases.

The report also discloses 246,040 shares beneficially owned following the transaction, establishing the director's total reported stake as recorded on this Form 4.

Amy M. Schumacher, una direttrice di Calumet, Inc. (CLMT), ha riportato la ricezione di 3.796 unità azionarie ristrette (RSU) il 24/06/2025. Le RSU sono descritte come l'equivalente economico di una singola quota e sono al 100% vestite. Ogni RSU è pagabile sia in una quota di azioni ordinarie Calumet sia nel contante equivalente, e il prezzo di acquisizione dichiarato è $0 (riflettendo l’emissione/settlement delle RSU piuttosto che un acquisto in contanti). Il rapporto riporta 246.040 azioni come importo di titoli di proprietà dopo la transazione. Il Form 4 è stato firmato da un procuratore-in-fatto per conto della persona che riporta il dato il 03/10/2025.

Amy M. Schumacher, directora de Calumet, Inc. (CLMT), informó haber recibido 3,796 unidades de stock restringido (RSU) el 24/06/2025. Se describe que las RSU son el equivalente económico de una acción cada una y están 100% vestidas. Cada RSU es pagadera ya sea en una acción ordinaria de Calumet o en su equivalente en efectivo, y el precio de adquisición informado es $0 (reflejando laemisión/ liquidación de RSU en lugar de una compra en efectivo). El informe lista 246,040 acciones como la cantidad de valores poseídos de manera beneficiosa tras la transacción. El Formulario 4 fue firmado por un apoderado en nombre de la persona informante el 03/10/2025.

Amy M. Schumacher, Calumet, Inc. (CLMT)의 이사로서, 2025년 6월 24일에 3,796개의 제한 주식 단위(RSU) 수령을 보고했습니다. RSU는 주당 경제적 등가물로 설명되며 전액 취득 상태입니다. 각 RSU는 Calumet 일반 주식 한 주 또는 그 현금가로 지급될 수 있으며 보고된 취득가액은 $0로 RSU의 발행/정산을 반영하는 현금 구매가 아님을 나타냅니다. 보고서는 거래 후 실제로 보유한 증권의 수량으로 246,040주를 기재합니다. Form 4는 보고자를 대신하여 대리인(법정대리인)이 2025년 10월 3일에 서명했습니다.

Amy M. Schumacher, directrice de Calumet, Inc. (CLMT), a signalé avoir reçu 3 796 unités d’actions restreintes (RSU) le 24/06/2025. Les RSU sont décrites comme l’équivalent économique d’une action et sont entierement acquises. Chaque RSU peut être payable soit en une action ordinaire Calumet, soit pour leur valeur en espèces, et le prix d’acquisition rapporté est $0 (reflétant l’émission/ liquidéation des RSU plutôt qu’un achat en numéraire). Le rapport indique 246 040 actions comme le montant des titres d’actifs détenus avantageusement après la transaction. Le Formulaire 4 a été signé par un mandataire au nom de la personne qui signale le document le 03/10/2025.

Amy M. Schumacher, Direktorin von Calumet, Inc. (CLMT), hat den Erhalt von 3.796 eingeschränkten Aktieneinheiten (RSU) am 24.06.2025 gemeldet. Die RSUs werden als wirtschaftliches Äquivalent zu einer Aktie beschrieben und sind vollständig vestet. Jede RSU ist entweder in einer Calumet-Ordinary-Share oder deren Barwert zahlbar, und der gemeldete Anschaffungspreis beträgt $0 (spiegelt die Ausgabe/Abwicklung der RSU wider statt eines Barankaufs). Der Bericht listet 246.040 Aktien als den Betrag der vorteilhaft gehaltenen Wertpapiere nach der Transaktion. Das Formular 4 wurde am 03.10.2025 von einem Bevollmächtigten im Namen der meldenden Person unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Schumacher Amy M
(Last) (First) (Middle)
1060 N CAPITOL AVE
SUITE 6-401
(Street)
INDIANAPOLIS IN 46204
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 06/24/2025 M 3,796 A $0 246,040 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 06/24/2025 M 3,796 (2) (2) Common Stock, par value $0.01 per share 3,796 $0 0 D
Explanation of Responses:
1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
2. Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested.
/s/ Connor J. Egan, as attorney-in-fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Amy M. Schumacher report on Form 4 for CLMT?

She reported acquisition of 3,796 Restricted Stock Units on 06/24/2025, which are 100% vested and payable in shares or cash.

How many shares does the Form 4 show after the transaction for CLMT?

The Form 4 lists 246,040 shares as the amount of securities beneficially owned following the reported transaction.

Was there a cash purchase price for the reported CLMT shares?

No; the transaction is reported with a price of $0, reflecting issuance/settlement of RSUs rather than a market purchase.

What is the settlement option for the RSUs reported on CLMT Form 4?

Each Restricted Stock Unit is payable either in one share of Calumet common stock or the cash value thereof, per the filing.

When was the Form 4 signed and who signed it?

The signature on the filed Form 4 is by Connor J. Egan, as attorney-in-fact, dated 10/03/2025.
Stock CLMT logo
Calumet

NASDAQ:CLMT

CLMT Rankings

#2317 Ranked by Market Cap
N/A Ranked by Dividends

CLMT Latest News

Aug 26, 2025
Calumet Provides Update After Latest U.S. EPA Small Refinery Exemption Decision
Aug 8, 2025
Calumet Reports Second Quarter 2025 Results
Aug 4, 2025
Eldridge Closes $120 Million Lease With Calumet
Aug 1, 2025
Calumet to Participate in September 2025 Investor Conferences
Jul 28, 2025
Calumet Announces $120 million Extension with Stonebriar

CLMT Latest SEC Filings

Oct 3, 2025
[Form 4] Calumet, Inc. /DE Insider Trading Activity
Oct 3, 2025
[Form 4] Calumet, Inc. /DE Insider Trading Activity
Oct 3, 2025
[Form 4] Calumet, Inc. /DE Insider Trading Activity
Oct 3, 2025
[Form 4] Calumet, Inc. /DE Insider Trading Activity
Oct 3, 2025
[Form 4] Calumet, Inc. /DE Insider Trading Activity

CLMT Stock Data

1.60B
67.64M
22.07%
51.52%
11.57%
Specialty Chemicals
Petroleum Refining
Link
United States
INDIANAPOLIS